{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T18:07:11Z","timestamp":1775153231220,"version":"3.50.1"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"crossref","award":["Grant No. cstc2021jcyj-msxmX0231"],"award-info":[{"award-number":["Grant No. cstc2021jcyj-msxmX0231"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Platelet-rich plasma (PRP) is increasingly applied in knee osteoarthritis (KOA), but its long-term efficacy remains uncertain. This study assessed 5-year outcomes of intra-articular PRP compared with conventional therapy in early-stage KOA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort of 116 patients with bilateral KOA (Kellgren\u2013Lawrence I\u2013II) treated in 2019 was analyzed. Group A (n\u2009=\u200958) received standardized management plus three PRP injections, while Group B (n\u2009=\u200958) received standardized conservative management alone (NSAIDs and\/or intra-articular hyaluronic acid), combined with education, exercise therapy, and weight management. Pain, function, and quality of life were evaluated by VAS, WOMAC, and SF-36 at baseline and 5 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Both groups showed deterioration over 5 years. VAS increased from 4.64\u2009\u00b1\u20090.52 to 5.41\u2009\u00b1\u20091.17 in Group A and from 4.80\u2009\u00b1\u20090.59 to 5.44\u2009\u00b1\u20091.16 in Group B, without significant between-group difference (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.849). WOMAC and SF-36 scores also worsened similarly, with no intergroup significance (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05). Intra-group analyses confirmed significant declines from baseline (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although a short, single course of leukocyte-poor PRP did not yield sustained superiority over standardized conservative management at 5 years, this real-world study provides rare long-term comparative evidence that defines the temporal boundaries of PRP efficacy and underscores the need for maintenance or optimized dosing protocols in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0344749","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:37:41Z","timestamp":1775151461000},"page":"e0344749","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Five-year real-world outcomes of short-course leukocyte-poor PRP versus standard conservative therapy in early-stage knee osteoarthritis"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1078-5193","authenticated-orcid":true,"given":"Qiuping","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenghong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3463-1006","authenticated-orcid":true,"given":"Junli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"issue":"9","key":"pone.0344749.ref001","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.joca.2025.05.011","article-title":"Ultra-processed food consumption is associated with knee osteoarthritis: Data from the Osteoarthritis Initiative","volume":"33","author":"Z Akkaya","year":"2025","journal-title":"Osteoarthritis Cartilage"},{"issue":"9","key":"pone.0344749.ref002","article-title":"Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"5","author":"GBD 2021 Osteoarthritis Collaborators","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"10","key":"pone.0344749.ref003","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.joca.2024.05.005","article-title":"The coexistence of diabetes, hypertension and obesity is associated with worse pain outcomes following exercise for osteoarthritis: A cohort study on 80,893 patients","volume":"32","author":"A Dell\u2019Isola","year":"2024","journal-title":"Osteoarthritis Cartilage"},{"issue":"6","key":"pone.0344749.ref004","article-title":"Current Non-surgical Management of Knee Osteoarthritis","volume":"15","author":"JA Mintarjo","year":"2023","journal-title":"Cureus"},{"key":"pone.0344749.ref005","doi-asserted-by":"crossref","first-page":"102870","DOI":"10.1016\/j.jcot.2024.102870","article-title":"Effect of platelet-rich plasma versus placebo or corticosteroid for knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials","volume":"62","author":"R Pelluri","year":"2024","journal-title":"J Clin Orthop Trauma"},{"issue":"2","key":"pone.0344749.ref006","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/jpm14020183","article-title":"Clinical Outcome of Multiple Platelet-Rich Plasma Injection and Correlation with PDGF-BB in the Treatment of Knee Osteoarthritis","volume":"14","author":"RU Partan","year":"2024","journal-title":"J Pers Med"},{"key":"pone.0344749.ref007","article-title":"Clinical efficacy analysis of autologous PRP combined with arthroscopy in the treatment of stage II-III KOA","author":"S Hou","year":"2024","journal-title":"Minerva Surg"},{"issue":"3","key":"pone.0344749.ref008","article-title":"The efficacy and safety of intra-articular platelet-rich plasma versus sodium hyaluronate for the treatment of osteoarthritis: Meta-analysis","volume":"20","author":"Q Liu","year":"2025","journal-title":"PLoS One"},{"issue":"10","key":"pone.0344749.ref009","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1007\/s00402-021-04230-2","article-title":"Multiple platelet-rich plasma injections are superior to single PRP injections or saline in osteoarthritis of the knee: the 2-year results of a randomized, double-blind, placebo-controlled clinical trial","volume":"142","author":"A Yurtbay","year":"2022","journal-title":"Arch Orthop Trauma Surg"},{"issue":"20","key":"pone.0344749.ref010","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1001\/jama.2021.19415","article-title":"Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial","volume":"326","author":"KL Bennell","year":"2021","journal-title":"JAMA"},{"key":"pone.0344749.ref011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/CMAMD.S17894","article-title":"Knee osteoarthritis injection choices: platelet-rich plasma (PRP) versus hyaluronic acid (a one-year randomized clinical trial)","volume":"8","author":"SA Raeissadat","year":"2015","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"issue":"12","key":"pone.0344749.ref012","first-page":"1833","article-title":"Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee","volume":"15","author":"N Bellamy","year":"1988","journal-title":"J Rheumatol"},{"issue":"6","key":"pone.0344749.ref013","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Jr Ware JE","year":"1992","journal-title":"Med Care"},{"key":"pone.0344749.ref014","doi-asserted-by":"crossref","first-page":"110925","DOI":"10.1016\/j.pnpbp.2023.110925","article-title":"Measuring pain intensity in older adults. Can the visual analogue scale and the numeric rating scale be used interchangeably?","volume":"130","author":"MT Bjelkaroy","year":"2024","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"pone.0344749.ref015","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1186\/s12891-023-06696-0","article-title":"Measurement properties of the short version of the Western Ontario and McMaster Universities Arthritis Index (WOMAC) for individuals with knee osteoarthritis","volume":"24","author":"JEF da Silva J\u00fanior","year":"2023","journal-title":"BMC Musculoskelet Disord"},{"issue":"11","key":"pone.0344749.ref016","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0895-4356(98)00081-X","article-title":"Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project","volume":"51","author":"Jr Ware JE","year":"1998","journal-title":"J Clin Epidemiol"},{"issue":"731","key":"pone.0344749.ref017","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf4590","article-title":"Single-cell atlas of human infrapatellar fat pad and synovium implicates APOE signaling in osteoarthritis pathology","volume":"16","author":"S Tang","year":"2024","journal-title":"Sci Transl Med"},{"issue":"5","key":"pone.0344749.ref018","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00167-015-3784-4","article-title":"Short-term outcomes of platelet-rich plasma injection for treatment of osteoarthritis of the knee","volume":"24","author":"W Kanchanatawan","year":"2016","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"2","key":"pone.0344749.ref019","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1302\/2046-3758.52.2000540","article-title":"Cytokine-release kinetics of platelet-rich plasma according to various activation protocols","volume":"5","author":"YH Roh","year":"2016","journal-title":"Bone Joint Res"},{"issue":"2","key":"pone.0344749.ref020","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3892\/etm.2021.10240","article-title":"Blocking TNF\u03b1 attenuates progressive cartilage matrix degradation in inflammatory arthritis","volume":"22","author":"J Park","year":"2021","journal-title":"Exp Ther Med"},{"issue":"2","key":"pone.0344749.ref021","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/0363546516665809","article-title":"Hyaluronic Acid Versus Platelet-Rich Plasma: A Prospective, Double-Blind Randomized Controlled Trial Comparing Clinical Outcomes and Effects on Intra-articular Biology for the Treatment of Knee Osteoarthritis","volume":"45","author":"BJ Cole","year":"2017","journal-title":"Am J Sports Med"},{"issue":"6","key":"pone.0344749.ref022","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/art.34453","article-title":"Osteoarthritis: a disease of the joint as an organ","volume":"64","author":"RF Loeser","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"1","key":"pone.0344749.ref023","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13018-017-0521-3","article-title":"The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"L Shen","year":"2017","journal-title":"J Orthop Surg Res"},{"key":"pone.0344749.ref024","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.reth.2025.04.002","article-title":"Platelet-rich plasma therapy for knee osteoarthritis: Insights from real-world clinical data in Japan","volume":"29","author":"Y Saita","year":"2025","journal-title":"Regen Ther"},{"key":"pone.0344749.ref025","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221100304","article-title":"Real-world evidence to assess the effectiveness of platelet-rich plasma in the treatment of knee degenerative pathology: a prospective observational study","volume":"14","author":"M S\u00e1nchez","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"pone.0344749.ref026","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/s13018-019-1363-y","article-title":"Intra-articular platelet-rich plasma injection for knee osteoarthritis: a summary of meta-analyses","volume":"14","author":"P Chen","year":"2019","journal-title":"J Orthop Surg Res"},{"issue":"12","key":"pone.0344749.ref027","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/j.arthro.2020.07.027","article-title":"The Cost-Effectiveness of Platelet-Rich Plasma Compared With Hyaluronic Acid Injections for the Treatment of Knee Osteoarthritis","volume":"36","author":"EM Samuelson","year":"2020","journal-title":"Arthroscopy"},{"issue":"3","key":"pone.0344749.ref028","article-title":"Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Trials","volume":"33","author":"W-L Dai","year":"2017","journal-title":"Arthroscopy"},{"issue":"3","key":"pone.0344749.ref029","doi-asserted-by":"crossref","first-page":"2325967120973284","DOI":"10.1177\/2325967120973284","article-title":"Effectiveness of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Clinical Trials","volume":"9","author":"L-Y Nie","year":"2021","journal-title":"Orthop J Sports Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0344749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:37:47Z","timestamp":1775151467000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0344749"}},"subtitle":[],"editor":[{"given":"Xindie","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0344749","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]}}}